Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
$2.29M
Dr. Michael Myers Ph.D.
4.00
Ashburn, VA
Oct 28, 2021
-0.11
$-5.05
1.08
3.55
0.00%
-0.03
0.04
0.00
3.50
-61.10%
-111.70%
Similar stocks (7)
Unicycive Therapeutics, Inc.
UNCY
NeuroBo Pharmaceuticals, Inc.
NRBO
Cardio Diagnostics Holdings, Inc.
CDIO
Revelation Biosciences, Inc.
REVB
Allarity Therapeutics, Inc.
ALLR
Kiromic BioPharma, Inc.
KRBP
PaxMedica, Inc.
PXMD
Similar stocks (7)
Unicycive Therapeutics, Inc.
UNCY
NeuroBo Pharmaceuticals, Inc.
NRBO
Cardio Diagnostics Holdings, Inc.
CDIO
Revelation Biosciences, Inc.
REVB
Allarity Therapeutics, Inc.
ALLR
Kiromic BioPharma, Inc.
KRBP
PaxMedica, Inc.
PXMD